1. Bevacizumab at first recurrence after standard radio-chemotherapy is associated with improved overall survival in glioblastoma patients with large tumor burden. Issue 2 (20th September 2018) Authors: Nguyen, Huy Tram; Nguyen, Nhung; Liu, Liang Yen; Dovek, Laura; Lenchner, Daniel; Harris, Robert; Ozer, Byram; Ravelo, Arliene; Sommer, Nicolas; Sim, Myung Shin; Elashoff, Robert; Green, Richard; Nghiemphu, Phioanh Leia; Cloughesy, Timothy Francis; Ellingson, Benjamin; Lai, Albert Journal: Neuro-oncology practice Issue: Volume 6:Issue 2(2019) Page Start: 103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗